The latest on Jon Jones has surfaced.

The former UFC champion failed an in-competition drug test at UFC 214. Due to that failed drug test, Jones has been provisionally suspended by USADA pending a full investigation by the CAC (California Athletic Commission).

Jones defeated his arch-rival Daniel Cormier by third-round TKO in the main event of UFC 214 on July 29 in Anaheim, California on PPV (pay-per-view) to regain the title. Jones tested positive for Turinabol.

Despite his success in the sport, he has had a long string of incidents that not only cost him money but opportunities to build his legacy.

Make no mistake about it, he is widely regarded as one of the greatest mixed martial artists of all time, Jones was ranked number one in the world during his championship reign and currently has the longest active winning streak in the UFC.

Jones has been stripped of three different UFC belts (also a record) and failed multiple drug tests by USADA to go along with myriad legal troubles outside of the cage.

He’s a two-time light heavyweight champion and the youngest fighter to ever hoist UFC gold. His first run as a UFC champion featured eight title defenses, tied for third-most of all time.

UFC President Dana White has written Jones off in the past by going on record that he would “never take the risk of headlining a show with Jon Jones again” after the fiasco Jones caused at UFC 200 by being forced off the card just days beforehand.

However, he booked Jones in the main event of UFC 214. In the past, UFC health and performance vice president Jeff Novitzky has gone on record by stating that Jones’ latest case is still being investigated.

Jones is facing a possible four-year suspension that even his own coaches say could end his career.

Even though he has been stripped of the UFC light heavyweight title and removed from the official UFC rankings after his latest failed drug test, he is still in the United States Anti-Doping Agency’s (USADA) drug testing pool.

Jones will attend a hearing in front of the CSAC on February 27 for his in-competition failure for anabolic steroid Turinabol. He’s expected to be handed a suspension and fine for his current case with the CSAC